TRxADE (NASDAQ: MEDS), an integrated drug procurement, delivery and health care marketplace platform that connects buyers and sellers, today announced the launch of the Trxade Prime Plus program. Released in collaboration with the company’s pharmaceutical wholesale business subsidiary, Integra Pharma Solutions LLC (d/b/a TRxADE Prime), the program will allow member pharmacies better access to over 20,000 pharmaceutical products available for next-day delivery without them incurring any additional shipping costs. “We are excited about the launch of TRxADE Prime Plus and feel confident that the offering will position our pharmacy buyers for success as delivery timelines can now be reduced significantly on the Trxade Prime program ensuring we meet our customers’ needs of on-demand inventory with as late as an 8 p.m. cutoff for next-day delivery,” said Jariel (Jay) Morales, executive vice president of operations for TRxADE. “Pharmacy partners that wish to join TRxADE Prime Plus will now be able to access even lower pricing on pharmaceuticals negotiated by TRxADE with national suppliers and the assurance and commitment of quality service without legacy chargeback or surcharge costs. We expect that this new program offering will improve gross revenues for TRxADE as there will be less deterrents for pharmacy buyers, as we continue to make it easier for our members to maximize their savings and thrive in today’s market.”
To view the full press release, visit https://ibn.fm/07hDA
About TRxADE Health Inc.
TRxADE is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The company operates the TRxADE drug procurement marketplace serving a total of 13,815+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For more information on TRxADE Health, please visit the company’s IR website at investors.trxadegroup.com.
NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.